Ackloo, Suzanne http://orcid.org/0000-0002-9696-1839
Al-awar, Rima
Amaro, Rommie E. http://orcid.org/0000-0002-9275-9553
Arrowsmith, Cheryl H.
Azevedo, Hatylas
Batey, Robert A. http://orcid.org/0000-0001-8808-7646
Bengio, Yoshua http://orcid.org/0000-0002-9322-3515
Betz, Ulrich A. K. http://orcid.org/0000-0002-4499-4313
Bologa, Cristian G. http://orcid.org/0000-0003-2232-4244
Chodera, John D. http://orcid.org/0000-0003-0542-119X
Cornell, Wendy D. http://orcid.org/0000-0002-7339-0201
Dunham, Ian http://orcid.org/0000-0003-2525-5598
Ecker, Gerhard F. http://orcid.org/0000-0003-4209-6883
Edfeldt, Kristina http://orcid.org/0000-0002-0550-1133
Edwards, Aled M. http://orcid.org/0000-0002-4782-6016
Gilson, Michael K. http://orcid.org/0000-0002-3375-1738
Gordijo, Claudia R. http://orcid.org/0000-0001-9054-0913
Hessler, Gerhard
Hillisch, Alexander http://orcid.org/0000-0002-4228-2347
Hogner, Anders http://orcid.org/0000-0003-3823-4534
Irwin, John J. http://orcid.org/0000-0002-1195-6417
Jansen, Johanna M. http://orcid.org/0000-0003-3937-6243
Kuhn, Daniel http://orcid.org/0000-0002-0550-4174
Leach, Andrew R. http://orcid.org/0000-0001-8178-0253
Lee, Alpha A.
Lessel, Uta http://orcid.org/0000-0002-1698-6017
Morgan, Maxwell R. http://orcid.org/0000-0002-4784-6113
Moult, John
Muegge, Ingo http://orcid.org/0000-0003-3294-1852
Oprea, Tudor I. http://orcid.org/0000-0002-6195-6976
Perry, Benjamin G. http://orcid.org/0000-0001-6715-4213
Riley, Patrick http://orcid.org/0000-0003-0797-0272
Rousseaux, Sophie A. L.
Saikatendu, Kumar Singh
Santhakumar, Vijayaratnam http://orcid.org/0000-0002-7001-557X
Schapira, Matthieu http://orcid.org/0000-0002-1047-3309
Scholten, Cora
Todd, Matthew H.
Vedadi, Masoud
Volkamer, Andrea http://orcid.org/0000-0002-3760-580X
Willson, Timothy M.
Article History
Accepted: 21 January 2022
First Online: 15 February 2022
Competing interests
: M.K.G. has an equity interest in and is a co-founder and scientific adviser of VeraChem LLC. J.J.I. is a co-founder of Blue Dolphin LLC, which undertakes fee-for-service ligand discovery. A. Hillisch is on the board of directors of the Structural Genomics Consortium (SGC) and the scientific advisory board of Cresset. A.A.L. is the chief scientific officer and a shareholder of PostEra Inc. T.I.O. has received honoraria from or consulted for Abbott, AstraZeneca, Chiron, Genentech, Infinity Pharmaceuticals, Merz Pharmaceuticals, Merck Darmstadt, Mitsubishi Tanabe, Novartis, Ono Pharmaceuticals, Pfizer, Roche, Sanofi and Wyeth, and is on the scientific advisory board of ChemDiv and InSilico Medicine. J.D.C. is a current member of the scientific advisory boards for OpenEye Scientific Software, Redesign Science, Interline Therapeutics and Ventus Therapeutics, and holds equity interests in Redesign Science and Interline Therapeutics. B.G.P. is on the board of directors of Evolia Therapeutics S.A. and the scientific advisory board of Spirochem A.G. All remaining authors declare no competing interests.